SterisMEX:STE N 90 ROA % is 8.27% as of Mar. 2026, which is 43% above its 10-year median of 5.78. GuruFocus rates MEX:STE N with a GF Score™ of 90/100 and a GF Value™ of MXN4,960.30. The stock has 1 warning sign investors should review. Among 857 Medical Devices & Instruments companies, Steris ranks better than 79% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Steris's annualizedNet Income for the quarter that ended in Mar. 2026 was MXN15,883 Mil.
Steris's average Total Assets over the quarter that ended in Mar. 2026 was MXN192,163 Mil. Therefore, Steris's annualized ROA % for the quarter that ended in Mar. 2026 was 8.27%.
The historical rank and industry rank for Steris's ROA % or its related term are showing as below:
MEX:STE N'
s ROA % Range Over the Past 10 Years
Min: 0.96 Med: 5.78 Max: 7.75
Current: 7.48
During the past 13 years, Steris's highest ROA % was 7.75%. The lowest was 0.96%. And the median was 5.78%.
MEX:STE N's ROA % is ranked better than 79% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.59
vs MEX:STE N: 7.48
Steris (MEX:STE N) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Steris ROA % Related Terms
Steris ROA % Historical Data
* Premium members only.
The historical data trend for Steris's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Steris's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's ROA % distribution charts can be found below:
* The bar in red indicates where Steris's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Steris (MEX:STE N) has a ROA % of 8.27% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Steris and its competitors. This is 43% above median its historical median of 5.78. Over the past decade, Steris' ROA % has ranged from 0.96 to 7.75. According to the industry distribution chart, Steris ranks #180 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is Steris' ROA % too high?
Steris' current ROA % of 8.27% is 43% above median its 10-year median of 5.78. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 7.75. The Medical Devices & Instruments industry median ROA % is 0.59. Steris' value of 8.27% is 1301.7% above this industry median. Based on the distribution chart, Steris ranks #180 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Steris has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Steris' ROA % compare to ZBH and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #180 out of 857 companies for ROA %. This places Steris in the top 21% of its industry — outperforming the majority of peers. The industry median ROA % is 0.59. Steris' value of 8.27% is 1301.7% above this benchmark. Historically, Steris' own ROA % has ranged from 0.96 to 7.75 over the past decade. While the company's 10-year median is 5.78 vs. the industry median of 0.59, Steris has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.59, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Steris's current ROA % of 8.27% is 1301.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Steris and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steris's current ROA % is 8.27%, which is 43% above median its own 10-year median of 5.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Steris (MEX:STE N) has a current ROA % of 8.27%. The stock's GF Value™ is MXN4,960.30, compared to a current price of MXN3,824.43 — trading 22.9% below its estimated fair value. The current ROA % is 8.27%, which is 43% above median its 10-year median of 5.78 and 1301.7% above the Medical Devices & Instruments industry median of 0.59. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Steris (MEX:STE N), the current ROA % is 8.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Steris (MEX:STE N) Overvalued in 2026?
Based on GuruFocus' analysis, Steris stock appears to be undervalued.
The current stock price of MXN3,824.43 is trading 22.9% below its estimated GF Value™ of MXN4,960.30.
Key valuation signals for MEX:STE N:
ROA %: 8.27% (43% above median its 10-year median of 5.78)
GF Value™: MXN4,960.30 vs. price of MXN3,824.43 (22.9% below fair value)
Industry Position: 1301.7% above the Medical Devices & Instruments median (#180 of 857)
No single metric tells the full story. See the MEX:STE N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score
Get the complete analysis for MEX:STE N
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:STE N has been successfully added to your 
